Form D · Other Technology
Medsense Health, Inc.
Tacoma, WA · CIK 0001957109
Offering snapshot reported Oct 1, 2025 · SEC filing
- Reported sold
- $4.02M Offering amount: $4.25M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 11, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,000,000 → $4,024,994
- Reported investors3 → 5
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2025 | Amendment | $4,024,994 | $3,024,994vs Aug 27, 2024 | 5 | SEC filing |
| Aug 27, 2024 | Amendment | $1,000,000 | $500,000vs Jan 23, 2024 | 3 | SEC filing |
| Jan 23, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 7, 2022 | Initial | $1,451,446 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503152
Source: Form D, filed Oct 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Bakken | Director |
| Clark Emerick | Director |
| Joel Martin | Director |
| Matthew Tabakin | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3304 N. 8 Th St.
Tacoma, WA, 98406
Tacoma, WA, 98406